TRIDENT Trademark

Trademark Overview

On Wednesday, June 17, 2015, a trademark application was filed for TRIDENT with the United States Patent and Trademark Office. The USPTO has given the TRIDENT trademark a serial number of 86665431. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2020. This trademark is owned by MacroGenics, Inc.. The TRIDENT trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases

Production, namely, pharmaceutical product and drug development; Drug discovery and research, and development of pharmaceuticals and substances in the nature of polypeptides, particularly antibodies and antibody derivatives, for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Drug discovery and research and development in the pharmaceutical and biotechnology fields; Research, development, and testing services in the fields of pharmaceutical and biotechnology products; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
trident

General Information

Serial Number86665431
Word MarkTRIDENT
Filing DateWednesday, June 17, 2015
Status700 - REGISTERED
Status DateTuesday, April 14, 2020
Registration Number6033941
Registration DateTuesday, April 14, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2016

Trademark Statements

Goods and ServicesProduct commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
Goods and ServicesProduction, namely, pharmaceutical product and drug development; Drug discovery and research, and development of pharmaceuticals and substances in the nature of polypeptides, particularly antibodies and antibody derivatives, for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Drug discovery and research and development in the pharmaceutical and biotechnology fields; Research, development, and testing services in the fields of pharmaceutical and biotechnology products; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2015
Primary Code035
First Use Anywhere DateTuesday, October 13, 2015
First Use In Commerce DateTuesday, October 13, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2015
Primary Code042
First Use Anywhere DateTuesday, October 13, 2015
First Use In Commerce DateTuesday, October 13, 2015

Trademark Owner History

Party NameMacroGenics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameMacroGenics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameMacroGenics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, December 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 4, 2015ASSIGNED TO EXAMINER
Friday, August 14, 2015NON-FINAL ACTION WRITTEN
Friday, August 14, 2015NON-FINAL ACTION E-MAILED
Friday, August 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 10, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 16, 2017TTAB RELEASE CASE TO TRADEMARKS
Wednesday, January 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 25, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, August 11, 2016OPPOSITION INSTITUTED NO. 999999
Monday, January 16, 2017OPPOSITION TERMINATED NO. 999999
Monday, January 16, 2017OPPOSITION DISMISSED NO. 999999
Thursday, February 15, 2018SOU EXTENSION 2 FILED
Thursday, February 15, 2018SOU EXTENSION 2 GRANTED
Thursday, August 16, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 16, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2017SOU EXTENSION 1 FILED
Wednesday, August 16, 2017SOU EXTENSION 1 GRANTED
Friday, August 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2018SOU TEAS EXTENSION RECEIVED
Saturday, February 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 16, 2018SOU EXTENSION 3 FILED
Thursday, August 16, 2018SOU EXTENSION 3 GRANTED
Saturday, August 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019SOU TEAS EXTENSION RECEIVED
Friday, February 15, 2019SOU EXTENSION 4 FILED
Friday, February 15, 2019SOU EXTENSION 4 GRANTED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2019SOU TEAS EXTENSION RECEIVED
Friday, August 9, 2019SOU EXTENSION 5 FILED
Wednesday, August 14, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 14, 2019SOU EXTENSION 5 GRANTED
Tuesday, March 10, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 14, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, January 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, February 13, 2020USE AMENDMENT FILED
Saturday, February 15, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 9, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, January 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

trident diseases development research disorders biotechnology pharmaceutical drug pharmaceuticals fields product